Text Size

"Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver

This study has been completed.
Sponsor:
Information provided by:
Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier:
NCT01408771
First received: August 2, 2011
Last updated: August 7, 2011
Last verified: July 2011
History of Changes
  Purpose

The purpose of this study is to find out whether swallowing has an effect on the degree of urinary urgency and on the amplitude of detrusor contraction during filling cystometry in patients with detrusor overactivity (DO).


Condition
Overactive Detrusor

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: "Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Assaf-Harofeh Medical Center:

Estimated Enrollment: 20
Study Start Date: April 2011
Study Completion Date: July 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Detailed Description:

Consecutive patients with DO will be included in this study. During urodynamics, the amplitude of the waves of DO will be documented and compared. At the beginning of the 2nd wave, patients will be asked to perform 5 repetitive swallows. Following each wave, patients will be asked to grade the severity of the urgency by a visual analogue scale (VAS).

  Eligibility

Ages Eligible for Study:   30 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients who are sedignated for urodynamic study with overactive bladder symptoms

Criteria

Inclusion Criteria:

patients with DO in filling cystometry

  • antimuscarinic medications were requested to stop for 7 days before the cystometry

Exclusion Criteria: none

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01408771

Sponsors and Collaborators
Assaf-Harofeh Medical Center
Investigators
Principal Investigator: Kobi Stav, MD Assaf Harofeh Medical Center, Zeriffin, Israel
  More Information

No publications provided

Responsible Party: Kobi Stav, Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier: NCT01408771     History of Changes
Other Study ID Numbers: 35/11
Study First Received: August 2, 2011
Last Updated: August 7, 2011
Health Authority: Israel: Ministry of Health

Keywords provided by Assaf-Harofeh Medical Center:
Urodynamics
Overactive Bladder

Additional relevant MeSH terms:
Urinary Bladder, Overactive
Urinary Bladder Diseases
Urologic Diseases
Urological Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on May 16, 2013